Bulletin
Investor Alert

Market Pulse Archives

Oct. 18, 2021, 3:47 a.m. EDT

Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Valneva SE (VLA)
  • X
    AstraZeneca PLC (AZN)

or Cancel Already have a watchlist? Log In

By Steve Goldstein

Valneva /zigman2/quotes/202377434/delayed FR:VLA +5.58% shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's /zigman2/quotes/203048482/delayed UK:AZN +0.74% in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.

/zigman2/quotes/202377434/delayed
FR : France: Euronext Paris
22.70
+1.20 +5.58%
Volume: 3.02M
Dec. 8, 2021 5:37p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
€2.26 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/203048482/delayed
UK : U.K.: London
8,284.00 p
+61.00 +0.74%
Volume: 1.70M
Dec. 8, 2021 4:35p
P/E Ratio
88.23
Dividend Yield
2.44%
Market Cap
£127.39 billion
Rev. per Employee
£282,763
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.